| 1 |
32987192 | TPGS2k-PLGA composite nanoparticles by depleting lipid rafts in colon cancer cells for overcoming drug resistance. | 2021 Jul |
3 |
| 2 |
28740256 | Influence of doxorubicin on model cell membrane properties: insights from in vitro and in silico studies. | 2017 Jul 24 |
2 |
| 3 |
27152239 | Multidrug resistance P-glycoprotein dampens SR-BI cholesteryl ester uptake from high density lipoproteins in human leukemia cells. | 2016 |
1 |
| 4 |
26484739 | Interaction of the P-Glycoprotein Multidrug Transporter with Sterols. | 2015 Nov 3 |
4 |
| 5 |
24624364 | Complex Interplay between the P-Glycoprotein Multidrug Efflux Pump and the Membrane: Its Role in Modulating Protein Function. | 2014 |
2 |
| 6 |
23684934 | A P-gp vesicular transport inhibition assay - optimization and validation for drug-drug interaction testing. | 2013 Jul 16 |
1 |
| 7 |
19389707 | Host cell P-glycoprotein is essential for cholesterol uptake and replication of Toxoplasma gondii. | 2009 Jun 26 |
3 |
| 8 |
19651114 | Lipid dependence of ABC transporter localization and function. | 2009 Oct |
2 |
| 9 |
16464592 | Methylated beta-cyclodextrin as P-gp modulators for deliverance of doxorubicin across an in vitro model of blood-brain barrier. | 2006 Apr 15 |
1 |
| 10 |
15240128 | Overexpression of caveolin-1 increases plasma membrane fluidity and reduces P-glycoprotein function in Hs578T/Dox. | 2004 Jul 30 |
1 |
| 11 |
15382145 | Raft and cytoskeleton associations of an ABC transporter: P-glycoprotein. | 2004 Oct |
1 |
| 12 |
15692732 | Decrease of P-glycoprotein activity in K562/ADR cells by MbetaCD and filipin and lack of effect induced by cholesterol oxidase indicate that this transporter is not located in rafts. | 2004 Dec |
1 |